TAP began in 1977 as a joint venture between two global pharmaceutical leaders, Abbott and Takeda Pharmaceutical Company Limited. Today, TAP is one of the nation's leading pharmaceutical companies and the marketer of Prevacid® (lansoprazole) and Lupron Depot® (leuprolide acetate for depot suspension), both leaders in their classes.

TAP knows the importance of diversity and recognizes that it makes the company more responsive and successful. TAP strives to create and maintain an environment that values the differences and similarities of people, enabling everyone to contribute to their full potential in pursuit of organizational objectives. These differences can mean anything from ethnic background to work styles. TAP continually promotes the understanding of diversity within the company and has efforts underway in the areas of retention, career development, and recruitment. TAP is actively looking for ways to advance diversity and has made it a priority in all facets of the business.

Print This Page

      Company Website